BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5774315)

  • 1. Cyclophosphamide therapy in the nephrotic syndrome in childhood.
    Moncrieff MW; White RH; Oggs CS; Cameron JS
    Br Med J; 1969 Mar; 1(5645):666-71. PubMed ID: 5774315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R; de Jong M; Monnens L
    Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth.
    Berns JS; Gaudio KM; Krassner LS; Anderson FP; Durante D; McDonald BM; Siegel NJ
    Am J Kidney Dis; 1987 Feb; 9(2):108-14. PubMed ID: 3826059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal-lesion nephrotic syndrome with early resistance to steroid therapy.
    Siegel NJ; Gur A; Krassner LS; Kashgarian M
    J Pediatr; 1975 Sep; 87(3):377-80. PubMed ID: 1165516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney biopsy prior to cyclophosphamide therapy in primary nephrotic syndrome.
    Mattoo TK
    Pediatr Nephrol; 1991 Sep; 5(5):617-9. PubMed ID: 1911150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS; Chantler C; Ogg CS; White RH
    Br Med J; 1974 Oct; 4(5935):7-11. PubMed ID: 4425844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome.
    Matsukura H; Inaba S; Shinozaki K; Yanagihara T; Hara M; Higuchi A; Takada T; Tanizawa T; Miyawaki T
    Am J Nephrol; 2001; 21(5):362-7. PubMed ID: 11684795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
    Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is biopsy required prior to cyclophosphamide in steroid-sensitive nephrotic syndrome?
    Stadermann MB; Lilien MR; van de Kar NC; Monnens LA; Schröder CH
    Clin Nephrol; 2003 Nov; 60(5):315-7. PubMed ID: 14640236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF; Farine M; Thorner P; Baumal R
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management Of Childhood Steroid Dependent Nephrotic Syndrome With Cyclophosphamide - An Experience At Ayub Teaching Hospital, Abbottabad.
    Hussain Shah SS; Aalia B; Raza A; Najeeb S; Rehman AU
    J Ayub Med Coll Abbottabad; 2021; 33(2):213-216. PubMed ID: 34137531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'?
    Doe JY; Funk M; Mengel M; Doehring E; Ehrich JH
    Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.